GFAP and Alzheimer disease: However, in a series of in vivo [11C]DED PET and GFAP immuno-reactivity studies for clinical and preclinical animal subjects, researchers have observed a dual-phase bimodal astrocyte activation pattern at different stages of AD disease course [31,33,34,35,36,37].